Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-20

Clinical Trial Update: A Study of LY3537031 in Overweight, Obese, and Healthy Participants [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for LY3537031 in overweight, obese, and healthy participants; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LY3537031 (LY3537031)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Overweight, Obesity | Phase 1 | Status: ACTIVE_NOT_RECRUITING